Cargando…
Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.
Previous studies have shown that tumour-suppressor genes play an important role in the progression of solid tumours. Recently, the p21WAF1/CIP1 tumour-suppressor protein has been reported to work as a critical downstream effector of p53 and a potent inhibitor of cyclin-dependent kinases. Thus, the p...
Autores principales: | Ogawa, M., Maeda, K., Onoda, N., Chung, Y. S., Sowa, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223544/ https://www.ncbi.nlm.nih.gov/pubmed/9184177 |
Ejemplares similares
-
Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019) -
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996) -
By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer
por: Zhang, Qing, et al.
Publicado: (2015) -
Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004) -
p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin
por: Molnar, Zoltan, et al.
Publicado: (2014)